1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The W(sh), W(57) and Ph c-Kit expression mutations define tissue specific control elements located between -24 and -150Kb upstream of c-Kit
    Meeting Abstract

    Berrozpe, G.; Timokhina, I.; Yukl, S.; Tajima, Y.; Ono, M.; Zelenetz, A.; Besmer, P.
    Experimental Hematology (1998)

    Fulltext@MSK | Save
  • Extended life span of human bone marrow endothelial cells transfected with human telomerase reverse transcriptase
    Meeting Abstract

    MacKenzie, K. L.; Franco, S.; Naiyer, A. J.; May, C.; Tan, C.; Peichev, M. A.; Sadelain, M.; Rafii, S.; Moore, M. A. S.
    Blood (1998)

    Fulltext@MSK | Save
  • Impact of initial response on disease progression following tandem peripheral blood stem-cell transplants (PBSCT) in patients (pts) with poor prognosis multiple myeloma (MM)
    Meeting Abstract

    Niesvizky, R.; Choy, C. G.; Fine, J.; Glassman, J.; Reich, L.; Straus, D.; Yahalom, J.; Zhu, A.; Michaeli, J.
    Blood (1998)

    Fulltext@MSK | Save
  • Complete remission after clinically induced differentiation and apoptosis in acute promyelocytic leukemia by arsenic trioxide
    Meeting Abstract

    Soignet, S. L.; Maslak, P.; Chen, Y. W.; Calleja, E.; Pandolfi, P. P.; Scheinberg, D. A.; Warrell, R. P.
    British Journal of Haematology (1998)

    Fulltext@MSK | Save
  • mAbs to the extracellular domain of prostate specific membrane antigen (PSMA)
    Meeting Abstract

    Liu, H.; Rajasekaran, A.; Scheinberg, D.; Sgouros, G.; Geerlings, M.; Vallabhajosula, S.; Hamilton, A.; King, S.; Carr, F.; Bander, N.
    Cancer Biotherapy and Radiopharmaceuticals (1998)

    Fulltext@MSK | Save
  • Risk of acute and chronic graft versus host disease (GvHD) associated with donor leucocyte infusion (DLI) decreases with time following HLA matched SBA-E-T cell depleted marrow grafts
    Meeting Abstract

    Jakubowski, A.; Small, T. N.; Collins, N.; Papadopoulos, E.; O'Reilly, R. J.
    Blood (1998)

    Fulltext@MSK | Save
  • Rapid selection of EBV-lymphoma specific T cells by transduction early after sensitization with a retroviral vector encoding a mutant NGFR and herpes simplex virus thymidine kinase gene
    Meeting Abstract

    Koehne, G.; Gallardo, H. F.; Sadelain, M.; O'Reilly, R. J.
    Blood (1998)

    Fulltext@MSK | Save
  • Dose-ranging study of arsenic trioxide in advanced hematologic cancers: Clinical pharmacokinetic and biological effects
    Meeting Abstract

    Soignet, S.; Wang, Z. G.; Nagy, J.; Maslak, P.; Chanel, S.; Ho, R.; Spriggs, D.; Ellison, R.; Pandolfi, P. P.; Warrell, R. P.
    Blood (1998)

    Fulltext@MSK | Save
  • Granulocyte-colony stimulating factor (G-CSF) may improve disease outcome in elderly patients with large cell lymphoma (LCL) treated with chop
    Meeting Abstract

    Donnelly, G. B.; Glassman, J.; Long, C.; Torres, P.; Straus, D. J.; O'Brien, J. P.; Zelenetz, A. D.; Moskowitz, C. H.; Portlock, C. S.
    Blood (1998)

    Fulltext@MSK | Save
  • Th use of stanford v overcomes poor prognostic features in patients with advanced stage Hodgkin's disease (HD)
    Meeting Abstract

    Moskowitz, C. H.; Yahalom, J.; Straus, D.; Portlock, C. S.; Goy, A.; O'Brien, J. P.; Zelenetz, A. D.
    Blood (1998)

    Fulltext@MSK | Save